Skip to main content

Advertisement

Table 1 Comparison of baseline characteristics (ITT analysis set)

From: Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke

Demographic parameter Cerebrolysin (n = 34) Placebo (n = 32)
Male sex: N (%) 29 (82.9) 24 (72.7)
Mean age: years (SD) 64.7 (10.1) 63.0 (10.6)
Mean weight: kg (SD) 65.4 (11.3) 66.7 (12.7)
Mean height: cm (SD) 165.7 (8.6) 165.7 (9.6)
Prevalence of risk factors: N (%)   
 Hypertension 20 (57.1) 11 (33.3)
 Hyperlipidemia 1 (2.9) 4 (12.1)
 Diabetes mellitus 10 (28.6) 9 (27.3)
 Arrhythmia 3 (8.6) 0 (0.0)
 Coronary artery disease 3 (8.6) 4 (12.1)
Stroke side: N (%), Rt : Lt 14 (41.2) : 20 (58.8) 20 (62.5) : 12 (37.5)
Stroke etiology: N (%)   
 Large artery atherosclerosis 13 (38.2) 11 (34.4)
 Small vessel occlusion 10 (29.4) 14 (43.8)
 Cardioembolism 7 (20.6) 4 (12.5)
 Other determined 1 (2.9) 1 (3.1)
 Undetermined ischemic stroke 3 (8.8) 2 (6.3)
Stroke lesion: N, cortical : subcortical : cortical-subcortical) 7: 6 : 21 8: 3 : 22
Stroke lesion characteristics   
 Cortex 7 8
 Cortex/BG/IC 3 0
 Cortex/BG/IC/Corona radiata 3 1
 Cortex/Corona radiata 0 2
 BG/IC 9 14
 BG/IC/Corona radiata 3 3
 Corona radiata 8 3
 Thalamus 1 2
Initial stroke treatment: N   
 Intravenous thrombolysis 5 3
 Intraarterial thrombolysis 1 2
 Intraarterial thrombectomy 2 2
Baseline stroke severity: Mean (SD)   
 NIHSS 8.4 (5.8) 7.0 (4.9)
 Lesion volumes: cm3 15.560 (27.023) 19.253 (18.846)
 Total FMA 42.0 (24.2) 42.2 (28.5)
 Upper limb of FMA 24.6 (18.8) 26.7 (20.7)
 Lower limb of FMA 17.4 (9.5) 15.5 (10.0)
  1. ITT intention-to-treat, BG basal ganglia, IC internal capsule, NIHSS National Institutes of Health Stroke Scale, FMA Fugl-Meyer assessment